OBEcure Ltd.
Quick facts
Marketed products
- Betahistine Extended Release formulation · Otolaryngology / Neurology
Betahistine is a histamine H1 receptor agonist and H3 receptor antagonist that increases blood flow to the inner ear and reduces endolymphatic pressure.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: